Zaniboni A - Search Results

1

Low-Dose Immunotherapy: Is It Just an Illusion?

Meriggi F, Zaniboni A, Zaltieri A. Meriggi F, et al. Among authors: zaniboni a. Biomedicines. 2023 Mar 27;11(4):1032. doi: 10.3390/biomedicines11041032. Biomedicines. 2023. PMID: 37189650 Free PMC article.

2

Phase II study of Taxol combined With ifosfamide and carboplatin in the treatment of stage IIIb-IV non-small-cell lung cancer.

Zaniboni A, Ardizzoni A, De Marinis F, Portalone L, Boni C, Meriggi F, Cafferata MA, Ariganello O, Torri V, Neumaier CE, Rosso R. Zaniboni A, et al. Am J Clin Oncol. 2003 Feb;26(1):84-8. doi: 10.1097/00000421-200302000-00016. Am J Clin Oncol. 2003. PMID: 12576930 Clinical Trial.

3

[Current methods in the treatment of iatrogenic neutropenia].

Meriggi F, Zaniboni A. Meriggi F, et al. Among authors: zaniboni a. Tumori. 2003 Nov-Dec;89(6):12-20. doi: 10.1177/030089160308900621. Tumori. 2003. PMID: 14870835 Review. Italian. No abstract available.

4

Non-small-cell lung cancer in the elderly.

Meriggi F, Zaniboni A. Meriggi F, et al. Among authors: zaniboni a. Crit Rev Oncol Hematol. 2006 Feb;57(2):183-90. doi: 10.1016/j.critrevonc.2005.06.004. Epub 2005 Oct 5. Crit Rev Oncol Hematol. 2006. PMID: 16169243 Review.

5

Molecular biology for stage II colorectal cancer: the jury is still out.

Cascinu S, Zaniboni A, Scartozzi M, Meriggi F. Cascinu S, et al. Among authors: zaniboni a. J Clin Oncol. 2007 Jul 1;25(19):2861; author reply 2862-3. doi: 10.1200/JCO.2006.10.0966. J Clin Oncol. 2007. PMID: 17602095 No abstract available.

6

Multidisciplinary team-working indicators of good practice in the clinical management of EGFR-inhibitor dermatologic toxicities.

Manganoni AM, Farisoglio C, Ferrari V, Zaniboni A, Beretta G, Meriggi F, Calzavara-Pinton P. Manganoni AM, et al. Among authors: zaniboni a. Ann Surg Oncol. 2009 Jan;16(1):224-5. doi: 10.1245/s10434-008-0200-z. Epub 2008 Nov 7. Ann Surg Oncol. 2009. PMID: 18989724 No abstract available.

7

Grading of severe follicular rash in patients receiving EGFR inhibitors.

Manganoni AM, Farisoglio C, Ferrari V, Zaniboni A, Beretta G, Meriggi F, Calzavara-Pinton P. Manganoni AM, et al. Among authors: zaniboni a. Ann Surg Oncol. 2010 Jan;17(1):349. doi: 10.1245/s10434-009-0714-z. Epub 2009 Oct 10. Ann Surg Oncol. 2010. PMID: 19821000 No abstract available.

8

Quality of life in colon cancer patients with skin side effects: preliminary results from a monocentric cross sectional study.

Andreis F, Rizzi A, Mosconi P, Braun C, Rota L, Meriggi F, Mazzocchi M, Zaniboni A. Andreis F, et al. Among authors: zaniboni a. Health Qual Life Outcomes. 2010 Apr 15;8:40. doi: 10.1186/1477-7525-8-40. Health Qual Life Outcomes. 2010. PMID: 20398332 Free PMC article.

9

Newer avenues for the treatment of leptomeningeal carcinomatosis.

Meriggi F, Zaniboni A. Meriggi F, et al. Among authors: zaniboni a. Cent Nerv Syst Agents Med Chem. 2011 Mar 1;11(1):38-44. doi: 10.2174/187152411794961068. Cent Nerv Syst Agents Med Chem. 2011. PMID: 21250935

10

Chemotherapy use at the end of life. A retrospective single centre experience analysis.

Andreis F, Rizzi A, Rota L, Meriggi F, Mazzocchi M, Zaniboni A. Andreis F, et al. Among authors: zaniboni a. Tumori. 2011 Jan-Feb;97(1):30-4. doi: 10.1177/030089161109700106. Tumori. 2011. PMID: 21528660

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

362 results

Search Page